rs111887056

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):​c.61G>C​(p.Ala21Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 1,586,544 control chromosomes in the GnomAD database, including 16,679 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1112 hom., cov: 33)
Exomes 𝑓: 0.14 ( 15567 hom. )

Consequence

GALC
NM_000153.4 missense

Scores

8
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.562
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018750429).
BP6
Variant 14-87993104-C-G is Benign according to our data. Variant chr14-87993104-C-G is described in ClinVar as [Benign]. Clinvar id is 92508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-87993104-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALCNM_000153.4 linkc.61G>C p.Ala21Pro missense_variant Exon 1 of 17 ENST00000261304.7 NP_000144.2 P54803-1A0A0A0MQV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkc.61G>C p.Ala21Pro missense_variant Exon 1 of 17 1 NM_000153.4 ENSP00000261304.2 P54803-1

Frequencies

GnomAD3 genomes
AF:
0.112
AC:
17026
AN:
152156
Hom.:
1109
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0395
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.119
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.0947
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.134
Gnomad NFE
AF:
0.154
Gnomad OTH
AF:
0.109
GnomAD3 exomes
AF:
0.115
AC:
21968
AN:
190848
Hom.:
1520
AF XY:
0.114
AC XY:
12010
AN XY:
105134
show subpopulations
Gnomad AFR exome
AF:
0.0329
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.000725
Gnomad SAS exome
AF:
0.0948
Gnomad FIN exome
AF:
0.148
Gnomad NFE exome
AF:
0.139
Gnomad OTH exome
AF:
0.121
GnomAD4 exome
AF:
0.142
AC:
203924
AN:
1434276
Hom.:
15567
Cov.:
33
AF XY:
0.141
AC XY:
100074
AN XY:
710896
show subpopulations
Gnomad4 AFR exome
AF:
0.0341
Gnomad4 AMR exome
AF:
0.139
Gnomad4 ASJ exome
AF:
0.117
Gnomad4 EAS exome
AF:
0.00124
Gnomad4 SAS exome
AF:
0.100
Gnomad4 FIN exome
AF:
0.158
Gnomad4 NFE exome
AF:
0.154
Gnomad4 OTH exome
AF:
0.131
GnomAD4 genome
AF:
0.112
AC:
17035
AN:
152268
Hom.:
1112
Cov.:
33
AF XY:
0.112
AC XY:
8361
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.0396
Gnomad4 AMR
AF:
0.130
Gnomad4 ASJ
AF:
0.119
Gnomad4 EAS
AF:
0.00232
Gnomad4 SAS
AF:
0.0946
Gnomad4 FIN
AF:
0.154
Gnomad4 NFE
AF:
0.154
Gnomad4 OTH
AF:
0.108
Alfa
AF:
0.140
Hom.:
554
Bravo
AF:
0.106
TwinsUK
AF:
0.139
AC:
517
ALSPAC
AF:
0.146
AC:
564
ESP6500AA
AF:
0.0366
AC:
109
ESP6500EA
AF:
0.115
AC:
777
ExAC
AF:
0.0887
AC:
10059
Asia WGS
AF:
0.0530
AC:
185
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Galactosylceramide beta-galactosidase deficiency Benign:5
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 21, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 03, 2013
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D;.
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.79
T;T
MetaRNN
Benign
0.0019
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.4
M;M
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
0.020
N;N
REVEL
Uncertain
0.51
Sift
Benign
0.072
T;D
Sift4G
Benign
0.13
T;T
Polyphen
1.0
D;.
Vest4
0.17
MPC
0.66
ClinPred
0.033
T
GERP RS
3.2
Varity_R
0.14
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111887056; hg19: chr14-88459448; COSMIC: COSV54324700; COSMIC: COSV54324700; API